Skip to content

DMT: all studies

Page 67 of 160: studies 661 to 670 of 1,593, newest first. Back to the DMT overview

Research

Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.

International Journal of Drug Policy July 9, 2026 François Gagnon, Anne Philibert, Benjamin Carignan et al.

Psychedelic retail stores illegally selling psilocybin, DMT and related substances have proliferated in Canada, with close to 60 brick-and-mortar shops documented in 2023. This echoes the pre-legalization and regulation cannabis landscape. Public responses have remained inconsistent, oscillating between de facto tolerance and enforcement of the law, raising concerns among public health...

DOI: 10.1016/j.drugpo.2026.105427 (opens in new tab) Full text (opens in new tab) Attitudes Knowledge Opinions Psychedelics stores +2

Policy Considerations for Psychedelics in Research and Medicine – What’s Next on the Schedule?

Journal of Science Policy & Governance July 2, 2026 Matthew A. Boehm, Oriana Mayorga

There is growing interest in psychedelic compounds such as psilocybin, 3,4-metheylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT) given emerging research on potential uses as treatments for a variety of health conditions. The United States Food and Drug Administration (FDA) has granted multiple “Breakthrough Therapy” designations to various...

Psicodélicos en psiquiatría: un modelo multidimensional para el análisis crítico del campo. Farmacología, actores y política sanitaria en la expansión terapéutica

Revista de Psiquiatría del uruguay July 1, 2026 María M. Penengo, Marta Vázquez, Laura Ramos et al.

página 48|Revista de Psiquiatría del Uruguay|Volumen 90 Nº 1 Julio 2026| Psicodélicos en psiquiatría: un modelo multidimensional para el análisis...Resumo Nos últimos anos, o renovado interesse pelo uso medicinal dos psicodélicos adquiriu um caráter hipermidiatizado, estendendo sua presença de contextos clínicos e rituais tradicionais para cenários mais amplos, nos quais os objetivos...

[Illicit use of classic psychedelics and suicidality: A systematic literature review].

L'Encephale July 1, 2026 Ana Beatriz Pereira de Oliveira, Matthieu Hein

INTRODUCTION Given the contrasting results available in the literature, the objective of this systematic review was to investigate the specific impact of illicit use of classic psychedelics (psilocybin, LSD, DMT, mescaline) on suicidality (suicidal ideation, suicide planning, suicide attempts, suicides). METHOD According to PRISMA criteria, a systematic review of the literature was carried out...

5-HT2A receptors in the prelimbic cortex VIP-expressing interneurons: A mechanism for psychedelic-induced innate fear attenuation.

British Journal of Pharmacology July 1, 2026 Yuanyuan Wang, Yishan Yao, Ruibin Su et al. 1 citation

Fear-related psychiatric disorders such as phobias and anxiety are insufficiently treated by current therapies. Psychedelics targeting 5-HT₂A receptors show promise in modulating fear circuits, but their specific neurobiological substrates remain unclear. This study investigates the effects of 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT), a psychedelic compound, on innate fear responses and...

DOI: 10.1111/bph.70307 (opens in new tab) Full text (opens in new tab) 4‐Aco‐DMT Innate fear Psychedelics Trimethylthiazoline +1

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 1, 2026 Guilherme Lodetti, Rafael Mariano de Bitencourt, Antonio Inserra et al.

BackgroundAlcohol use disorder (AUD) remains difficult to treat with lasting success, leading to growing interest in alternative therapeutic approaches. Psychedelic compounds such as Ayahuasca, a traditional brew used in Indigenous Amazonian ceremonies containing N,N-dimethyltryptamine (DMT) along with monoamine oxidase-inhibiting β-carbolines, have shown promise in reducing addictive...

DOI: 10.1016/j.pnpbp.2026.111817 (opens in new tab) Ayahuasca Serotonin Oxidative stress Glutathione peroxidase +12

Neuroestimulantes naturales: de rituales ancestrales a terapias de vanguardia

Revista CienciaUANL July 1, 2026 Armando Ordaz‐hernández, M. Corona-Ramírez, Israel Jesús Orlando Guerrero

La psilocibina, presente en los “hongos mágicos”, y la 5-MeO-DMT, secretada por el sapo Incilius alvarius, fueron empleadas ancestralmente en rituales espirituales en México. Hoy, la ciencia las reconoce como terapias prometedoras contra depresión, ansiedad, estrés postraumático y adicciones resistentes a tratamientos convencionales. Actúan sobre receptores de serotonina y estimulan la...

DOI: 10.29105/cienciauanl29.138-5 (opens in new tab) Addiction Mental health Clinical practice Psychotherapist

Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.

Pharmacology, Biochemistry, and Behavior June 30, 2026 Lucie Ladislavová, Viera Kútna, Kristýna Mazochová et al.

Psilocin (4-hydroxy-N, N-dimethyltryptamine) is a substituted tryptamine alkaloid and a nonselective serotonergic agonist acting predominantly at 5-HT2A/C receptors, with substantial binding to 5-HT1A and 5-HT2B receptors. Microdosing is the practice of taking a very small, sub-perceptual dose, typically 5% to 10% of a full recreational dose, to improve mood, creativity, and focus without...

Vaporized mebufotenin leads to improvement in treatment‐resistant depression

The Brown University Psychopharmacology Update June 28, 2026

An individualized one‐day dosing regimen of a vaporized formulation of the psychedelic mebufotenin (5‐methoxy‐ N,N ‐dimethyltryptamine; 5‐MeO‐DMT) was more effective than placebo in improving depressive symptoms in adults with treatment‐resistant depression, a Phase 2b trial has found. No serious treatment‐emergent adverse events were reported during the 7‐day study. Results were published...

DOI: 10.1002/pu.31471 (opens in new tab) Anxiety Depression economics Adverse effect Dosing +5

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review

Journal of Psychopharmacology June 26, 2026 Flavia Giaffone de Paiva Ferreira, João Ariel Bonar Fernandes, Renato Filev et al.

With growing research on the use of psychedelics to treat mental health conditions, greater attention to the psychosocial procedures accompanying substance administration is warranted. This scoping review aims to categorize psychosocial protocols used in research involving psychedelics as psychiatric treatment according to their purpose, denomination, format, therapeutic orientation,...

DOI: 10.1177/02698811261453850 (opens in new tab) Psychosocial Categorization Observational study Flexibility engineering +15